Lenz Therapeutics, Inc

This study tested the long-term safety of LNZ101 eye drops for presbyopia, a common age-related condition that makes it hard to see things up close. A total of 362 adults aged 45 to 75 took part. The main goal was to check for side effects related to the treatment.

This study tested an eye drop called LNZ101 to improve near vision in people with presbyopia, an age-related condition that makes it hard to see close up. 229 adults aged 45-75 took part. The main goal was to see if the drop could give a big improvement in reading vision without …

This study tested an eye drop called LNZ101 to help people with presbyopia, an age-related condition that makes it hard to see things up close. 469 adults aged 45-75 took part. The main goal was to see if the drops could improve near vision by at least 3 lines on an eye chart wit…